• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Takeda needs to acquire Synergy to get it's mojo back in PCP. Trulance already dominating Linzess

Quote

anonymous

Guest
That's right, the launch trajectory is being set for Trulance and it's already doubling that of the Linzess launch. Trulance is making history and will be the most successful CIC/IBS-C drug in the history of medicine. Amitiza is on life support, everyone knows it. Takeda doesn't even own worldwide rights to Amitiza, they would for Trulance if they acquired Synergy. PCP reps that care about your jobs, send a signal to upper management and tell them you want Trulance in your bag.
Here's a place tracking the Trulance vs Linzess launch

https://sites.google.com/view/trustat/prescription-numbers
 




Are these rumors legti? We have a great specially team at Publicis launching Trulance for Synergy. We could really use the help in PCP, would love to work for Takeda and be GI specialty rep here. We have many former Salix reps, great GI experience that would love to come on board when everything gets inked.
 
















anonymous said:
They better win it if they actually want to have a PCP business. I actually think after Uloric runs it's course they will go specialty and scale down the sales force. NSS and GI.
3/31/18 gonna be another "restructure" just makes sense. Save your money...
Click to expand...

How could you buy it when you have a marketing agreement with sucampo
 




Top Bottom
Back
Quote